Literature DB >> 9306945

Fatal pulmonary embolism in hospitalised medical patients.

T P Baglin1, K White, A Charles.   

Abstract

This study aimed to determine the frequency of fatal pulmonary emboli in hospitalised medical patients by a retrospective necropsy review and prospective non-interventional patient follow up study. The main outcome measure, necropsy proven fatal pulmonary embolism, was determined from 400 consecutive necropsy records and 200 consecutive medical inpatient episodes. Fatal pulmonary embolism was recorded in 29 of 400 necropsies; 17 were medical patients. Thirty one of 200 consecutive medical patients died. Fourteen necropsies were performed and revealed pulmonary embolism as the cause of death in five patients. The incidence of necropsy proven fatal pulmonary embolism was therefore 2.5% (95% confidence intervals 0.8% to 5.7%). Therefore, one in 40 medical patients had pulmonary embolism recorded as the cause of death at necropsy. As the necropsy rate was only 45% the incidence of fatal pulmonary embolism may be greater. There is, therefore, a need to perform more large prospective studies to confirm the incidence of fatal pulmonary embolism in medical patients and to identify risk factors and effective antithrombotic prophylaxis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9306945      PMCID: PMC500077          DOI: 10.1136/jcp.50.7.609

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Heparin prophylaxis in bedridden patients.

Authors:  J F Bergmann; C Caulin
Journal:  Lancet       Date:  1996-07-20       Impact factor: 79.321

2.  Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?

Authors:  D A Sandler; J F Martin
Journal:  J R Soc Med       Date:  1989-04       Impact factor: 5.344

3.  Incidence of deep vein thrombosis in bedridden non-surgical patients.

Authors:  A Kierkegaard; L Norgren; C G Olsson; J Castenfors; G Persson; S Persson
Journal:  Acta Med Scand       Date:  1987

Review 4.  Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery.

Authors:  R Collins; A Scrimgeour; S Yusuf; R Peto
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

5.  Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis.

Authors:  H Halkin; J Goldberg; M Modan; B Modan
Journal:  Ann Intern Med       Date:  1982-05       Impact factor: 25.391

6.  178 fatal cases of pulmonary embolism in a medical department.

Authors:  H K Nielsen; P Bechgaard; P F Nielsen; S E Husted; E Geday
Journal:  Acta Med Scand       Date:  1981

7.  Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis.

Authors:  M T Nurmohamed; F R Rosendaal; H R Büller; E Dekker; D W Hommes; J P Vandenbroucke; E Briët
Journal:  Lancet       Date:  1992-07-18       Impact factor: 79.321

8.  Low molecular weight heparin in prevention of perioperative thrombosis.

Authors:  A Leizorovicz; M C Haugh; F R Chapuis; M M Samama; J P Boissel
Journal:  BMJ       Date:  1992-10-17

9.  Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: a randomized double-blind trial.

Authors:  R Dahan; D Houlbert; C Caulin; E Cuzin; C Viltart; M Woler; J M Segrestaa
Journal:  Haemostasis       Date:  1986
  9 in total
  24 in total

Review 1.  Review of race/ethnicity in non vitamin K antagonist oral anticoagulants clinical trials.

Authors:  Larry R Jackson; Eric D Peterson; Eze Okeagu; Kevin Thomas
Journal:  J Thromb Thrombolysis       Date:  2015-02       Impact factor: 2.300

2.  Fatal pulmonary embolism in hospitalised patients: a necropsy review.

Authors:  R Alikhan; F Peters; R Wilmott; A T Cohen
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

3.  Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.

Authors:  Alexander T Cohen; Bruce L Davidson; Alexander S Gallus; Michael R Lassen; Martin H Prins; Witold Tomkowski; Alexander G G Turpie; Jan F M Egberts; Anthonie W A Lensing
Journal:  BMJ       Date:  2006-01-26

4.  Venous thromboembolism prophylaxis guideline compliance: a pilot study of augmented medication charts.

Authors:  R Cunningham; A Murray; J S Byrne; L Hammond; M Barry; D Mehigan; S Sheehan
Journal:  Ir J Med Sci       Date:  2014-07-15       Impact factor: 1.568

5.  Is deep vein thrombosis prophylaxis appropriate in the medical wards? A clinical pharmacists' intervention study.

Authors:  Hossein Khalili; Simin Dashti-Khavidaki; Azita Hajhossein Talasaz; Laleh Mahmoudi; Kaveh Eslami; Hamed Tabeefar
Journal:  Pharm World Sci       Date:  2010-07-13

6.  Incidence of venous thromboembolism in care homes: a prospective cohort study.

Authors:  Patricia N Apenteng; Fd Richard Hobbs; Andrea Roalfe; Usman Muhammad; Carl Heneghan; David Fitzmaurice
Journal:  Br J Gen Pract       Date:  2017-01-16       Impact factor: 5.386

7.  Snoring and the risk of obstructive sleep apnea in patients with pulmonary embolism.

Authors:  Matthew D Epstein; Leopoldo N Segal; Sherin M Ibrahim; Neil Friedman; Rami Bustami
Journal:  Sleep       Date:  2010-08       Impact factor: 5.849

8.  Venous thromboembolism prophylaxis for hospitalized medical patients, current status and strategies to improve.

Authors:  Hikmat Abdel-Razeq
Journal:  Ann Thorac Med       Date:  2010-10       Impact factor: 2.219

Review 9.  Prevention of venous thromboembolism in hospitalized patients with cancer.

Authors:  Charles W Francis
Journal:  J Clin Oncol       Date:  2009-08-24       Impact factor: 44.544

10.  Improved venous thromboembolism prophylaxis by pharmacist-driven interventions in acutely ill medical patients in Belgium.

Authors:  Audrey Vervacke; Sophie Lorent; Serge Motte
Journal:  Int J Clin Pharm       Date:  2014-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.